Canada - English - Health Canada

pendopharm division of pharmascience inc - montelukast (montelukast sodium) - tablet - 10mg - montelukast (montelukast sodium) 10mg - leukotriene modifiers

Canada - English - Health Canada

sivem pharmaceuticals ulc - montelukast (montelukast sodium) - tablet (chewable) - 4mg - montelukast (montelukast sodium) 4mg - leukotriene modifiers

Canada - English - Health Canada

sivem pharmaceuticals ulc - montelukast (montelukast sodium) - tablet (chewable) - 5mg - montelukast (montelukast sodium) 5mg - leukotriene modifiers

Canada - English - Health Canada

sivem pharmaceuticals ulc - montelukast (montelukast sodium) - tablet - 10mg - montelukast (montelukast sodium) 10mg - leukotriene modifiers

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - montelukast sodium, quantity: 10.4 mg (equivalent: montelukast, qty 10 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; hyprolose; hypromellose; titanium dioxide; iron oxide red; iron oxide yellow; carnauba wax - prophylaxis and treatment of chronic asthma in adults and children two years of age and older. symptomatic treatment of seasonal allergic rhinitis

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - montelukast sodium, quantity: 5.2 mg (equivalent: montelukast, qty 5 mg) - tablet, chewable - excipient ingredients: mannitol; hyprolose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; iron oxide red; aspartame; flavour - prophylaxis and treatment of chronic asthma in adults and children two years of age and older. symptomatic treatment of seasonal allergic rhinitis

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - montelukast sodium, quantity: 4.16 mg (equivalent: montelukast, qty 4 mg) - tablet, chewable - excipient ingredients: mannitol; hyprolose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; iron oxide red; aspartame; flavour - prophylaxis and treatment of chronic asthma in adults and children two years of age and older. symptomatic treatment of seasonal allergic rhinitis

Australia - English - Department of Health (Therapeutic Goods Administration)

torrent australasia pty ltd - montelukast sodium, quantity: 10.4 mg (equivalent: montelukast, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; mannitol; croscarmellose sodium; aspartame; iron oxide yellow; iron oxide red; flavour - prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. symptomatic treatment of seasonal allergic rhinitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

torrent australasia pty ltd - montelukast sodium, quantity: 5.2 mg (equivalent: montelukast, qty 5 mg) - tablet, chewable - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; mannitol; aspartame; iron oxide red; flavour - prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. symptomatic treatment of seasonal allergic rhinitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

torrent australasia pty ltd - montelukast sodium, quantity: 4.16 mg (equivalent: montelukast, qty 4 mg) - tablet, chewable - excipient ingredients: aspartame; magnesium stearate; microcrystalline cellulose; mannitol; croscarmellose sodium; iron oxide red; flavour - prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. symptomatic treatment of seasonal allergic rhinitis.